Abbisko Cayman (STU:8ZD) Days Sales Outstanding : 0.00 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Abbisko Cayman Days Sales Outstanding?

Abbisko Cayman's average Accounts Receivable for the six months ended in Dec. 2024 was €0.00 Mil. Abbisko Cayman's Revenue for the six months ended in Dec. 2024 was €0.88 Mil. Hence, Abbisko Cayman's Days Sales Outstanding for the six months ended in Dec. 2024 was 0.00.

The historical rank and industry rank for Abbisko Cayman's Days Sales Outstanding or its related term are showing as below:

STU:8ZD's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 70.64
* Ranked among companies with meaningful Days Sales Outstanding only.

Abbisko Cayman's Days Sales Outstanding stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).

Abbisko Cayman Days Sales Outstanding Historical Data

The historical data trend for Abbisko Cayman's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Days Sales Outstanding Chart

Abbisko Cayman Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

Abbisko Cayman Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Abbisko Cayman's Days Sales Outstanding

For the Biotechnology subindustry, Abbisko Cayman's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbisko Cayman's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abbisko Cayman's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Abbisko Cayman's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Abbisko Cayman Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Abbisko Cayman's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	66.108	*	365
=	0					/	66.108	*	365
=	0.00

Abbisko Cayman's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0.881	*	365 / 2
=	0					/	0.881	*	365 / 2
=	0.00

Abbisko Cayman (STU:8ZD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Abbisko Cayman Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbisko Cayman Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (STU:8ZD) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

02256:Hong Kong 8ZD:Germany

Address

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

https://www.abbisko.com

Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman Headlines

No Headlines